Journal
NATURE REVIEWS MICROBIOLOGY
Volume 2, Issue 2, Pages 166-173Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrmicro822
Keywords
-
Categories
Funding
- NIGMS NIH HHS [R01 GM091875] Funding Source: Medline
Ask authors/readers for more resources
Following a sixty-year hiatus in western medicine, bacteriophages (phages) are again being advocated for treating and preventing bacterial infections. Are attempts to use phages for clinical and environmental applications more likely to succeed now than in the past? Will phage therapy and prophylaxis suffer the same fates as antibiotics - treatment failure due to acquired resistance and ever-increasing frequencies of resistant pathogens? Here, the population and evolutionary dynamics of bacterial-phage interactions that are relevant to phage therapy and prophylaxis are reviewed and illustrated with computer simulations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available